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Higher phagocytic activity of thioglycollate-
elicited peritoneal macrophages is related
to metabolic status of the cells
Sofia Pavlou, Luxi Wang, Heping Xu and Mei Chen*
Abstract
Background: Peritoneal macrophages are widely used in immunological studies. The cells can be collected under
non-elicited (resident) or elicited (e.g., with Brewer thioglycollate broth injection) conditions, and their phenotype
and functions differ. Recent studies have shown that macrophage phenotype and function are related to their
metabolic states, and metabolic reprogramming has been an emerging concept for controlling macrophage
function. In this study, we examined the metabolic state of resident and elicited macrophages and investigated
how their metabolic state may affect cell function, including phagocytosis.
Findings: Flow cytometry showed that elicited macrophages expressed higher levels of MHC-II, LFA-1 and CD64
but lower levels of F4/80 compared to naïve resident peritoneal macrophages, suggesting a more mature and
active phenotype. Elicited macrophages had significantly higher levels of phagocytic activity compared to that of
resident macrophages. Metabolic studies showed that the Extracellular Acidification Rates (ECAR) and Oxygen
Consumption Rates (OCR) were both significantly higher in elicited macrophages than those in resident macrophages.
The treatment of macrophages with 2-Deoxy-D-glucose suppressed glycolysis and reduced phagocytosis, whereas
treatment with oligomycin enhanced glycolysis and increased phagocytosis in elicited macrophages.
Conclusion: Naïve resident peritoneal macrophages are less metabolically active compared to elicited macrophages.
Elicited macrophages had higher levels of glycolysis and oxidative phosphorylation, which may be related to their
increased phagocytic capacity and higher levels of maturation and activation. Further understanding of the molecular
links between metabolic pathways and cell function would be crucial to develop strategies to control macrophage
function through metabolic reprogramming.
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Introduction
Macrophages are mononuclear cells distributed throughout
the body and play a critical role in both innate and adaptive
immunity. Peritoneal macrophages are useful tools to study
the pathophysiology of tissue macrophages. The peritoneal
lavage collection has been a well-established method of
harvesting a relatively large number of fully differentiated
macrophages from rodents [1]. Peritoneal macrophages
are often collected either under non-elicited (resident
macrophage) or elicited conditions (elicited macrophage),
with sterile agents such as Brewer’s thioglycollate broth.
The phenotypical and functional differences between
resident and elicited peritoneal macrophages are well
documented in the literature [2]. Recent evidence suggests
that metabolic choices in cells enforce fate and function.
How the phenotype and function of resident and elicited
macrophages are regulated by metabolic pathways
remains poorly defined. Therefore, in this study we in-
vestigated the metabolic state of resident and elicited
macrophages and examined the link between metabolic
state and function, in particular their phagocytic capacity.
Methods
Animals
12-week old C57BL/6 J mice were bred and maintained in
the Biological Service Unit at Queens University Belfast
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in a 12 h-light/12 h-dark cycle with free access to
water and chows. The use of animals was in compli-
ance with the UK Home Office Animal (Scientific Proce-
dures) Act 1986 and was approved by the local Ethical
Review Committee.
Cell collection
Peritoneal macrophages were harvested using the protocol
as described previously [1]. Elicited macrophages were
harvested from mice which had received a 1.5 ml intraper-
itoneal administration of 3% Brewer thioglycollate broth
(Sigma, UK) 72 h prior collection. Resident macrophages
were also harvested from non-injected mice.
Flow cytometry
Cell suspensions were processed for staining of cell sur-
face markers, including F4/80 (clone BM8), LFA-1 (clone
2D7), MHCII (clone AF6-120.1), CD16/CD32 (clone
2.4G2) (BD Biosciences, UK), CD64 (clone X54-5/7.1,
BioLegend, UK). Data was collected using the BD FACS-
Canto II (BD Biosciences) and analysed using the FlowJo
software (Tree Star Inc, CA, USA).
Phagocytosis assays
Phagocytic activity of macrophages was assessed using
the pHrodo S.aureus bioparticles conjugate phagocytosis
kit and the Dextran-FITC phagocytosis system (Thermo-
Fisher Scientific, UK) according to the manufacture’s in-
struction and previous publication [3]. Macrophages
were seeded onto a black-walled 96-well plate for 2 h at
a density of 5×104/well followed by incubation with 2-
Deoxy-D-glucose (2-DG) or oligomycin. The pHrodo
S.aureus bioparticles were then added at a ratio of
10:1(bioparticles : macrophages) for 2 h before fluores-
cence intensity was measured using the Fluostar Omega
plate reader (BMG Labtech). Culture medium alone with
bioparticles was served as negative control. The net
phagocytosis was calculated by subtracting the average
fluorescence intensity of the no-cell negative controls
from the experimental wells [3]. 1×105 macrophages
were incubated with Dextran-FITC (1 mg/ml) at 37 °C
for 60 mins, and counter-stained with F4/80 antibody
and analysed via FACSCanto II. Phagocytosis of dextran-
FITC was expressed as MFI (mean fluorescent intensity).
Cell viability
AlamarBlue® Cell Viability (ThermoFisher Scientific) was
performed according to manufacturer’s guidelines.
Bioenergetic study
Macrophage glycolytic function was assessed using
Seahorse XF Glycolysis Stress Test Kit with a seahorse
XF96 Analyser (all from Agilent Technologies, USA)
following manufacturer’s instructions. Macrophages
were seeded at a density of 3×106 /well onto the 96-well
microplate (Agilent Technologies) for 2 h prior to the
assay. The glycolytic activities were assessed by measuring
the Extracellular Acidification Rates (ECAR). Glycolysis is
the ECAR after the addition of glucose. Glycolytic capacity
is the increase in ECAR after the injection of oligomycin
following glucose. Glycolytic reserve is the difference be-
tween glycolytic capacity and glycolysis. The Oxygen Con-
sumption Rates (OCR) before any stimulation were
calculated from the glycolysis stress test. Data were nor-
malised with the cell number and expressed as mpH/min/
103 cells (ECAR) or pmol/min/103 cells (OCR).
Immunoblotting
Total protein extraction and Western blots were performed
according to a previous publication [4]. Membranes were
incubated with antibodies against glucose transporter 1
(Glut1, rabbit anti mouse, 1:1000, Millipore, UK), or β-actin
(mouse anti-mouse, 1:2000, Santa Cruz Biotech, USA),
followed by goat anti-rabbit IRDye® IgG 800CW or goat
anti-mouse IRDye 680 conjugated secondary antibodies
(LI-COR Biosciences, UK) respectively. Corresponding
bands were detected using Odyssey infrared imaging
system (Li-COR Biosciences). Densitometric analysis
was performed using ImageJ software.
Statistical analysis
Data were represented as mean ± SEM and analysed
using unpaired, two-tailed Student’s t-test or one way
ANOVA followed by Dunnett Test. P < 0.05 was con-
sidered statistically significant.
Results and discussion
Active Phagocytosis of elicited macrophages is associated
with their phenotype
Phagocytosis is an inherent function of tissue macrophages
and important for host protection and the initiation of the
innate and adaptive immune response. Peritoneal macro-
phages are frequently used to study the phagocytic activity
of tissue macrophages. The elicited macrophages demon-
strated a significantly higher level of phagocytic activity
compared to resident macrophages in both the pHrodo S.
aureus bioparticles phagocytosis assay (Fig. 1a) and the
Dextran-FITC phagocytosis assay (Fig. 1b-c). The pH based
plate-reader method (Fig. 1a) revealed a higher level of
difference between these two types of macrophages
compared to the Dextran–based flow cytometric assay
(Fig. 1b-c). Acidification is essential during phagosome
maturation. The fluorescence of the pHrodo® dye dramat-
ically increases as pH decreases from neutral to acidic in
the phagolysosomes. This assay not only detects the up-
take of particles, but also measures the formation of
phagolysosomes. This data suggests that lysosomes in
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Fig. 1 The phenotype and phagocytic function of resident and elicited peritoneal macrophages. Fresh peritoneal macrophages were processed
for phagocytosis (a-c) or cell surface markers analysis (d-h). a Phagocytosis measured by the pHrodo S.aureus bioparticles assay. b, c Phagocytosis
using the Dextran-FITC and measured by flow cytometry. c Representative histogram of Flow cytometry data showing Dextran-FITC uptake by
macrophages. d Mean fluorescence intensity (MFI) of F4/80. e The percentage of CD16/CD32+ and CD64+ cells in resident and elicited peritoneal
macrophages. f Representative dot-plot FACS images showing CD16/CD32 and CD64 expression in resident and elicited macrophages. g & h MFI of
cell surface molecule LFA-1 (g) and MHC-II (h). Mean ± SEM, N = 4 mice. *p < 0.05; **p < 0.01; ***p < 0.001. Student’s t test
Fig. 2 Glycolytic activities of elicited and resident macrophages. Fresh peritoneal macrophages were seeded in 96-well plate for 2 h and glycolytic
activities were examined using XF Analyser. a Non-glycolytic acidification. b Non-mitochondrial respiration. c A representative graph output from
XF96 showing ECAR response to glucose, oligomycin and 2-DG. d Glycolysis. e Glycolytic capacity. f Glycolytic reserve. (g & h) Western blot analysis of
Glut 1. Mean ± SEM, n = 3-4 mice *p < 0.05, **P < 0.01, ***p < 0.001**. Student’s t test
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elicited macrophages are more active than those from
resident macrophages.
To understand the mechanism underlying the difference
in phagocytosis between resident and elicited macro-
phages, we further examined the phenotype of the cells.
Flow cytometry analysis revealed higher fluorescence in-
tensity of F4/80 in resident macrophages compared to
elicited macrophages (Fig. 1d). The result is in line with a
previous report in BALB/c mice [2], suggesting that the
genetic background does not affect macrophage differenti-
ation. Phagocytosis is often mediated by cell surface mole-
cules such as scavenger receptors, mannose receptors, and
complement receptors. Flow cytometric analysis revealed
no significant difference on the percentage of CD16/CD32
+ cells between resident and elicited macrophages (Fig. 1e).
However the percentage of CD64+ cells was significantly
lower in resident macrophages compared to that in elic-
ited macrophages (Fig. 1e). Interestingly, almost all CD64+
macrophages expressed CD16/CD32 (Fig. 1f) on elicited
macrophages. CD64 is recognised as a marker for mature
tissue macrophages [5] and monocyte-derived dendritic
cells [6]. Our data suggest that elicited macrophages are in
a more mature state than resident macrophages. In
addition, the elicited macrophages expressed higher levels
of LFA-1 (Fig. 1g), and MHCII (Fig. 1h) compared to resi-
dent macrophages, suggesting higher levels of activation.
Higher metabolic activity in elicited macrophages
Macrophage phagocytosis is fuelled by glycolysis and
requires the presence of extracellular glucose [7, 8]. In
the glucose-free, glutamine-present media, resident macro-
phages demonstrated lower levels of non-glycolytic acidifi-
cation (Fig. 2a, p < 0.01) and non-mitochondrial respiration
(Fig. 2b, p < 0.001) compared to elicited macrophages. Since
these cells were equilibrated in glutamine containing media,
we speculate that glutamine oxidation may contribute to
the higher level of non-glycolytic acidification in elicited
macrophages via the increased CO2 production in the
mitochondria. These results suggest that resident mac-
rophages utilise limited amounts of glucose and oxygen,
and are metabolically inactive.
Using sequential addition of glucose, oligomycin and
2-DG in the XF96 analyzer, we further examined gly-
colysis, glycolytic reserve and glycolytic capacity of resi-
dent and elicited macrophages. After the addition of
glucose, ECAR was significantly increased in elicited
but not resident macrophages (Fig. 2c-d). When oligomycin
was injected to inhibit oxidative phosphorylation, ECAR
Fig. 3 Effect of glycolysis inhibition in macrophage phagocytosis and phenotype. Fresh elicited peritoneal macrophages were treated with
different concentrations of 2-DG for 1 h. Phagocytosis was measured using the pHrodo S.aureus bioparticles kit and cell viability by AlamarBlue®
assay. The expression of F4/80, CD16/32, and CD64 was evaluated by flow cytometry. a ECAR in control and 2-DG treated macrophages. b Phagocytosis of
pHrodo S.aureus bioparticles in control and 2-DG treated macrophages. c Macrophage viability following 2-DG treatment. d Representative flow cytometry
data showing the expression levels of F4/80, CD16/32 and CD64 in control and 2-DG treated macrophages. e The percentage of F4/80+, CD16/32+ and
CD64+ cells in control un-treated (UT) and 2-DG treated macrophages. Mean ± SEM, N= 4 mice. *p< 0.05, **p< 0.01, ***p< 0.001, One-way ANOVA,
followed by Dunnett’s test
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level was further increased in elicited macrophages, suggest-
ing higher levels of glycolytic capacity (Fig. 2c, e). Resident
macrophage failed to respond to the stimulation (Fig. 2c).
Glycolytic reserve, the difference between glycolytic capacity
and glycolysis rate was also significantly higher in elicited
macrophages compared to that in resident macrophages
(Fig. 2f). Our results suggest that elicited macrophages have
a higher capacity to utilise glucose for energy supply and en-
force functions.
Glut-1 is the major glucose transporter expressed in
macrophages [9]. Western blot revealed a 2.75-fold increase
in Glut-1 expression in elicited macrophages compared
to resident macrophages (Fig. 2g-h, p < 0.01). Our re-
sults suggest that the elicited macrophages may uptake
glucose through Glut-1 to maintain high metabolic
activities.
Regulating macrophage phagocytic capacity by
manipulating glycolysis
To further understand how macrophage phagocytosis is
regulated by metabolic pathways, we used chemicals known
to inhibit or enhance the glycolysis pathway. 2-DG, a
nonmetabolizable glucose analog to glucose hexokinase
inhibited glycolysis (Fig. 3a) and reduced phagocytosis
(Fig. 3b) in macrophages, although the inhibitory effect
was not dose-dependent. 2-DG treatment reduced cell
viability (Fig. 3c). The expression of F4/80, CD16/
CD32 or CD64 (Fig. 3d and e) in elicited macrophages
remained unchanged, suggesting that the reduction in
phagocytosis is likely due to the direct effect of gly-
colysis inhibition.
Oligomycin inhibits mitochondrial oxidative phosphor-
ylation by blocking the F0 subunit of the H+-ATPase. The
treatment of macrophages with oligomycin increased
glycolysis (Fig. 4a) and enhanced phagocytosis (Fig. 4b).
Short-term (15 min) inhibition of mitochondrial oxida-
tive phosphorylation did not affect cell viability (Fig. 4c)
and the expression of F4/80, CD16/CD32 or CD64
(Fig. 3d and e) in elicited macrophages, suggesting that
the enhanced phagocytic capacity is the direct result of
metabolic switch.
Conclusion
Elicited peritoneal macrophages are metabolically more
active compared to naïve resident macrophages. Both the
glycolysis and oxidative phosphorylation pathways are
active in elicited macrophages. The metabolic difference
may be related to the phenotypic and functional variations
observed in these two types of macrophages, including the
difference in phagocytosis. Further understanding the mo-
lecular mechanisms that control the metabolic pathways
will shed light on the link between metabolism and func-
tion in macrophages.
Fig. 4 Effect of oligomycin in macrophage phagocytosis and phenotype. Fresh elicited peritoneal macrophages were treated with different
concentrations of oligomycin for 15 min. Phagocytosis was measured using the pHrodo S.aureus bioparticles kit and cell viability by
AlamarBlue® assay. The expression of F4/80, CD16/32, and CD64 was evaluated by flow cytometry. a ECAR in control and oligomycin
treated cells. b Phagocytosis of pHrodo S.aureus bioparticles in control and oligomycin treated macrophages. c Macrophage viability
following oligomycin treatment. d Representative flow cytometry data showing the expression levels of F4/80, CD16/32 and CD64 in control and
olygomycin treated macrophages. e The percentage of F4/80+, CD16/32+ and CD64+ cells in un-treated (UT) and oligomycin treated macrophages.
Mean ± SEM, N = 4 mice. *p < 0.05, Student t test in a and One-way ANOVA, followed by Dunnett’s test in b
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